SB 1096: Regulation of Compounded Drug Products
GENERAL BILL by Brodeur
Regulation of Compounded Drug Products; Requiring the Surgeon General, on behalf of the Department of Health, to sign and become a party to the United States Food and Drug Administration’s Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products; requiring certain pharmacy permittees to annually report information to the National Association of Boards of Pharmacy’s information sharing network as required by the memorandum, etc.
Effective Date: Except as otherwise expressly provided in this act, this act shall take effect upon becoming a law
Last Action: 3/14/2022 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Last Action: 3/14/2022 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Senate Committee References:
- Health Policy (HP)
- Regulated Industries (RI)
- Rules (RC)
-
Bill History
Date Chamber Action 11/30/2021 Senate • Filed
12/13/2021 Senate • Referred to Health Policy; Regulated Industries; Rules -SJ 73
1/11/2022 Senate • Introduced -SJ 73
3/12/2022 Senate • Indefinitely postponed and withdrawn from consideration
3/14/2022 Senate • Died in Health Policy
-
SB 1096, Original Filed Version (Current Bill Version) Posted 11/30/2021 at 2:11 PM
Bill Text: Web Page | PDF Analyses: None Related Bills (2)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills H 1109 Distribution of Compounded Human Drug Products Buchanan Similar Last Action: 3/14/2022 H Died in Professions & Public Health Subcommittee 
H 693 (c2) Department of Health Professions and Public Health Subcommittee Compare Last Action: 3/8/2022 H Laid on Table; companion bill(s) passed, see CS/CS/SB 768 (Ch. 2022-71), CS/SB 566 (Ch. 2022-29)
Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 465.036 Page 2 (pdf)